TickerFacts.

Cencora, Inc. (COR): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2011-09-30, 2014-09-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$3.68B
Year ended 2025-09-30
$4.08B
Trailing 12 months to 2026-06-30
+6.3%
3-year compound annual growth
+18.6%
10-year compound annual growth
2010-09-30: $1.18B2011-09-30: $1.29B2012-09-30: $1.44B2013-09-30: $1.06B2014-09-30: $970.77M2015-09-30: $670.86M2016-09-30: $1.89B2017-09-30: $1.46B2018-09-30: $1.91B2019-09-30: $1.57B2020-09-30: -$4.74B2021-09-30: $2.86B2022-09-30: $3.06B2023-09-30: $3.30B2024-09-30: $3.27B2025-09-30: $3.68B$3.68B
2010-09-30 EBITDA (USD) 2025-09-30
Period endedEBITDAChange YoYSource filing
2025-09-30$3.68B+12.6%2025-11-25, From 2024-10-01
2024-09-30$3.27B-1.1%2025-11-25, From 2023-10-01
2023-09-30$3.30B+8.0%2025-11-25, From 2022-10-01
2022-09-30$3.06B+7.0%2024-11-26, From 2021-10-01
2021-09-30$2.86Bn/m2023-11-21, From 2020-10-01
2020-09-30-$4.74Bn/m2022-11-22, From 2019-10-01
2019-09-30$1.57B-17.5%2021-11-23, From 2018-10-01
2018-09-30$1.91B+30.9%2020-11-19, From 2017-10-01
2017-09-30$1.46B-22.9%2019-11-19, From 2016-10-01
2016-09-30$1.89B+181.8%2018-11-20, From 2015-10-01
2015-09-30$670.86M-30.9%2017-11-21, From 2014-10-01
2014-09-30$970.77Mn/c2016-11-22, From 2013-10-01
2013-09-30$1.06B-26.2%2015-11-24, From 2012-10-01
2012-09-30$1.44B+11.4%2014-11-25, From 2011-10-01
2011-09-30$1.29Bn/c2013-11-26, From 2010-10-01
2010-09-30$1.18Bn/a2012-11-27, From 2009-10-01

EBITDA at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Cencora, Inc. (COR)2025-09-30$3.68B+12.6%
McKesson Corp (MCK)2026-03-31$6.94B+37.2%
Cardinal Health Inc (CAH)2026-06-30$3.57B+16.4%
Herbalife Ltd. (HLF)2025-12-31$602.20M+18.7%
Nu Skin Enterprises, Inc. (NUS)2025-12-31$118.02Mn/m
Cosmos Health Inc. (COSM)2025-12-31-$15.33Mn/m
DataMeds AI, Inc. (MEDS)2025-12-31-$90.54Mn/m
Stemtech Corp (STEK)2025-12-31-$2.54Mn/m

Compare COR, MCK, CAH, HLF side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗